PLx Pharma (PLXP) Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE and Substantially All of its Assets Apr 12, 2023 05:27PM
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets Apr 12, 2023 05:24PM
PLx Pharma (PLXP) Receives Nasdaq Delisting Notice Apr 11, 2023 04:29PM
PLx Pharma Inc. Receives Nasdaq Delisting Notice Apr 11, 2023 04:28PM
PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update Nov 10, 2022 05:00PM


Sep 12, 2022 04:30PM Baseball Legend John Smoltz Featured on PLx Pharma’s Social Channels
Aug 12, 2022 07:00AM Survey: Cardiovascular Patients on Aspirin Therapy Prefer VAZALORE® 81 mg
Aug 12, 2022 06:50AM PLx Pharma Inc. Reports Second Quarter 2022 Results and Provides Business Update